OGEVITY Trademark

Trademark Overview

On Friday, May 1, 2020, a trademark application was filed for OGEVITY with the United States Patent and Trademark Office. The USPTO has given the OGEVITY trademark a serial number of 88897981. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 5, 2022. This trademark is owned by Ogevity Therapeutics, Inc.. The OGEVITY trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a full line of therapeutic pharmaceutical, pharmaceutical, medical and veterinary preparations; therapeutic pharmaceutical and pharmaceutical preparations for treatment or prevention of systemic diseases, cardiovascular diseases, neurodegenerative diseases, metabolic syndrome, diabetes mellitus, obesity, cancer, oncology, dyslipidemia, infectious diseases, degenerative and inflammatory diseases, urologic diseases, sexual dysfunction, osteoporosis, sepsis, hepatitises, and HIV/AIDS; transdermal preparations, namely, transdermal creams for delivery of pharmaceuticals; anti-inflammatory preparations; antiseptic preparations; topical analgesic creams; anesthetic spray for topical use; decongestants; antifungal preparations; anti-infective pharmaceutical preparations
ogevity

General Information

Serial Number88897981
Word MarkOGEVITY
Filing DateFriday, May 1, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 5, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements

Goods and ServicesHouse mark for a full line of therapeutic pharmaceutical, pharmaceutical, medical and veterinary preparations; therapeutic pharmaceutical and pharmaceutical preparations for treatment or prevention of systemic diseases, cardiovascular diseases, neurodegenerative diseases, metabolic syndrome, diabetes mellitus, obesity, cancer, oncology, dyslipidemia, infectious diseases, degenerative and inflammatory diseases, urologic diseases, sexual dysfunction, osteoporosis, sepsis, hepatitises, and HIV/AIDS; transdermal preparations, namely, transdermal creams for delivery of pharmaceuticals; anti-inflammatory preparations; antiseptic preparations; topical analgesic creams; anesthetic spray for topical use; decongestants; antifungal preparations; anti-infective pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOgevity Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressConcord, NC 28027
Party NameOgevity Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressConcord, NC 28027

Trademark Events

Event DateEvent Description
Monday, December 5, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 5, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, April 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 20, 2022SOU EXTENSION 3 GRANTED
Wednesday, April 20, 2022SOU EXTENSION 3 FILED
Wednesday, April 20, 2022TEAS EXTENSION RECEIVED
Thursday, November 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 10, 2021SOU EXTENSION 2 GRANTED
Monday, November 1, 2021SOU EXTENSION 2 FILED
Monday, November 1, 2021TEAS EXTENSION RECEIVED
Wednesday, June 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 2, 2021CORRECTED NOA E-MAILED
Tuesday, June 1, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, April 28, 2021DIVISIONAL REQUEST RECEIVED
Tuesday, June 1, 2021SOU EXTENSION 1 GRANTED
Wednesday, April 28, 2021SOU EXTENSION 1 FILED
Monday, May 24, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 28, 2021TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, April 28, 2021TEAS EXTENSION RECEIVED
Tuesday, March 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 5, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 27, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 27, 2020NON-FINAL ACTION E-MAILED
Monday, July 27, 2020NON-FINAL ACTION WRITTEN
Friday, July 24, 2020ASSIGNED TO EXAMINER
Thursday, May 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 5, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

ogevity preparations diseases pharmaceutical creams transdermal inflammatory topical anti therapeutic hepatitises